APA (7th ed.) Citation

Mitchell, S., Spurkland, A., Boberg, K., Chapman, R., Fleming, K., Schrumpf, E., & Cholangit, E. (1998). Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?

Chicago Style (17th ed.) Citation

Mitchell, SA, A. Spurkland, K. Boberg, R. Chapman, K. Fleming, E. Schrumpf, and E. Cholangit. Is the 308 Polymorphism in the Tumor Necrosis Factor (alpha) (TNF Alpha) Promoter Region a Marker of Disease Susceptibility in European Patients with Primary Sclerosing Cholangitis (PSC)? 1998.

MLA (9th ed.) Citation

Mitchell, SA, et al. Is the 308 Polymorphism in the Tumor Necrosis Factor (alpha) (TNF Alpha) Promoter Region a Marker of Disease Susceptibility in European Patients with Primary Sclerosing Cholangitis (PSC)? 1998.